A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

The following is a summary of “Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the ...

While the recent study by the Human Sciences Research Council (HSRC) revealed that people living with HIV in KwaZulu-Natal ...

Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...

Nomonde Ngema, 21, who was born with HIV, not only tackles the stigma on TikTok by sharing her journey, she also takes on ...

Abstract HIV/AIDS remains a critical public health issue in Ghana, with recent data indicating a troubling increase in the ...